Lyophilized recombinant CK-MB2 is a suitable and accessible reference material for standardizing CK-MB mass assays, reducing between-manufacturer bias to 13%.
Authors
No takes yet. Share an insight, caveat, or question.
May warrant further assay harmonization efforts; leaves open whether residual bias affects clinical CK-MB interpretation.
Christenson et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: